Clinical Trial Update: Evaluation of Safety and Efficacy of rhNGF in Patients With Stage 2 and 3 Neurotrophic Keratitis. [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluating safety and efficacy of rhNGF in stage 2–3 neurotrophic keratitis completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Ulcer
• Keratitis
• Neurotrophic Keratitis

Drugs mentioned

• rhNGF (recombinant human nerve growth factor)

Snippet

Sponsor: Dompé Farmaceutici S.p.A | Conditions: Neurotrophic Keratitis, Keratitis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-07-29